Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mayuko Wada"'
Publikováno v:
Drug Design, Development and Therapy, Vol 2009, Iss default, Pp 213-217 (2009)
Shinichiro Ryuge1, Shi-Xu Jiang2, Mayuko Wada1, Ken Katono1, Maiko Iwasaki1, Akira Takakura1, Sakiko Otani1, Yuka Kimura1, Tomoya Fukui1, Masanori Yokoba1, Masaru Kubota1, Masato Katagiri1, Kazusige Hayakawa3, Noriyuki Masuda11Department of Respirato
Externí odkaz:
https://doaj.org/article/7716ee03002a4fdf9f8edb9df31dc1ed
Autor:
Kenji Morihashi, Shoji Nishino, Minoru Morimoto, Hiroyuki Saimoto, Takehiro Fujita, Masato Sumita, Shinsuke Ifuku, Mayuko Wada, Hironori Izawa
Publikováno v:
Bulletin of the Chemical Society of Japan. 91:1220-1225
1-Methyl-3-(N-(1,8-naphthalimidyl)ethyl)imidazolium can be a discriminator for anionic polysaccharides via monomer-excimer switching and photo-induced colorimetric reaction. In the system, the exci...
Autor:
Ken Katono, Michiko Kimura, Maiko Asakuma, Michiko Yamamoto, Hisashi Mitsufuji, Masaru Kubota, Jiichiro Sasaki, Sakiko Otani, Akira Takakura, Noriyuki Masuda, Mayuko Wada, Masato Katagiri, Mikiko Ishihara, Tomoya Fukui, Satoshi Igawa, Nobuatsu Hayashi, Shinichiro Ryuge, Masanori Yokoba, Hideyuki Saito, Masashi Kasajima, Issei Toyooka, Akinobu Hamada, Yasuhiro Hiyoshi, Sachiyo Maki
Publikováno v:
American Journal of Clinical Oncology. 38:405-410
Objectives We conducted a phase I trial of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with amrubicin, a topoisomerase II inhibitor. The aim was to determine the maximum tolerated dose, the dose-limiting toxicit
Autor:
Nobuyuki Yamamoto, Takashi Seto, Mayuko Wada, Asuka Tsuya, Tateaki Naito, Hideyuki Harada, Satoshi Igawa, Kyoichi Kaira, Noriyuki Masuda, Tetsuo Nishimura, Kazushige Hayakawa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 82:1777-1782
Purpose To investigate the safety and efficacy of concurrent vinorelbine and thoracic radiotherapy in elderly patients with locally advanced non–small-cell lung cancer (NSCLC). Methods and Materials Eligible patients were 71 years of age or older w
Autor:
Akira Takakura, Hisashi Mitsufuji, Mayuko Wada, Masaru Kubota, Sakiko Otani, Sachiyo Maki, Ken Katono, Maiko Asakuma, Jiichiro Sasaki, Tomoko Yanaihara, Tomoya Fukui, Shinichiro Ryuge, Masanori Yokoba, Michiko Yamamoto, Satoshi Igawa, Noriyuki Masuda, Masato Katagiri
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:1529-1536
We conducted a phase I trial of irinotecan (CPT-11), a topoisomerase I inhibitor, combined with amrubicin, a topoisomerase II inhibitor, with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support to overcome the neutropenia associ
Publikováno v:
Journal of Molecular Liquids. 166:31-39
The effects of clusters on the crystal growth were investigated by a molecular dynamics (MD) simulation. Sodium chloride was selected as a sample and the initial growth process was treated in this paper. As the concentration was higher, the solute io
Autor:
Jiichiro Sasaki, Sachiyo Maki, Akira Takakura, Noriyuki Masuda, Satoshi Igawa, Shinichiro Ryuge, Ken Katono, Mayuko Wada, Yuichi Sato, Sakiko Otani
Publikováno v:
Chemotherapy. 58:313-320
The purpose of this study was to evaluate the efficacy of pemetrexed monotherapy in previously treated patients with advanced non-small cell lung cancer (NSCLC) including salvage treatment, and to evaluate whether thymidylate synthase (TS) expression
Autor:
Masanori Yokoba, Naohito Ishii, Hisashi Mitsufuji, Masaru Kubota, Tsuyoshi Ichikawa, Noriyuki Masuda, Masato Katagiri, Mayuko Wada
Publikováno v:
International Journal of Clinical Medicine. :270-275
Superior vena cava syndrome (SVCS) patients sometimes show signs of obstructive sleep apnea (OSA). However, the mechanism causing hypoxia during sleep in SVCS patients is still uncertain. The aim of this study was to elucidate 1) the changes in centr
Autor:
Shinichiro Ryuge, Sakiko Otani, Nobuatsu Hayashi, Masanori Yokoba, Satoshi Igawa, Tomoko Yanaihara, Michiko Yamamoto, Noriyuki Masuda, Akira Takakura, Y. Nagashima, Mayuko Wada, Masato Katagiri, Sachiyo Maki, Ken Katono, Hisashi Mitsufuji, Masaru Kubota
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:1005-1011
In this phase II clinical trial, we evaluated the efficacy and safety of S-1 monotherapy in patients with previously treated advanced non-small-cell lung cancer (NSCLC). We also measured plasma concentrations of 5-fluorouracil (5-FU) and 5-chloro-2,4
Publikováno v:
Journal of Pediatric Orthopaedics. 31:674-678
BACKGROUND Shortening of the ulna is one of the characteristic features of the radial longitudinal deficiency, which could be treated with repeated bone lengthening. The purpose of this study is to assess the changes in growth rate of the ulna after